TriSalus Life Sciences, Inc. (TLSI)
NASDAQ: TLSI · Real-Time Price · USD
4.650
+0.185 (4.14%)
At close: Mar 9, 2026, 4:00 PM EDT
4.615
-0.035 (-0.75%)
After-hours: Mar 9, 2026, 4:10 PM EDT
TriSalus Life Sciences Employees
TriSalus Life Sciences had 102 employees as of December 31, 2025. The number of employees decreased by 8 or -7.27% compared to the previous year.
Employees
102
Change (1Y)
-8
Growth (1Y)
-7.27%
Revenue / Employee
$410,464
Profits / Employee
-$633,545
Market Cap
285.07M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 102 | -8 | -7.27% |
| Dec 31, 2024 | 110 | -2 | -1.79% |
| Dec 31, 2023 | 112 | 37 | 49.33% |
| Dec 31, 2022 | 75 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Viemed Healthcare | 1,380 |
| Standard BioTools | 818 |
| Cerus | 630 |
| Quanterix | 471 |
| RxSight | 461 |
| 908 Devices | 246 |
| Sight Sciences | 216 |
| Delcath Systems | 156 |
TLSI News
- 4 days ago - TriSalus Life Sciences, Inc. (TLSI) Q4 2025 Earnings Call Transcript - Seeking Alpha
- 4 days ago - TriSalus Life Sciences Reports Fourth Quarter and Year-End 2025 Results and Reaffirms 2026 Revenue Guidance - Business Wire
- 12 days ago - TriSalus Life Sciences to Host Fourth Quarter 2025 Financial Results Conference Call - Business Wire
- 17 days ago - TriSalus Life Sciences Announces Pricing of $40.0 Million Public Offering - Business Wire
- 18 days ago - TriSalus Life Sciences Proposes Public Offering - Business Wire
- 4 weeks ago - TriSalus Life Sciences Appoints Veteran Healthcare Investor Michael Stansky to its Board of Directors - Business Wire
- 2 months ago - TriSalus Life Sciences Announces Preliminary Fourth Quarter and Full-Year 2025 Results and 2026 Revenue Guidance - Business Wire
- 3 months ago - TriSalus Life Sciences, Inc. (TLSI) Discusses Innovative Approaches for Thyroid Artery Embolization and Tumor-Targeted Therapies Transcript - Seeking Alpha